Safer Macrophage-Based Immunotherapy Combo Shows Promise Against Ewing Sarcoma
Researchers have replaced the toxic components of a macrophage-directed immunotherapy for Ewing sarcoma with cyclophosphamide and the erythrocyte-sparing antibody lemzoparlimab, ...
